Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,088 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Epoetin requirements predict mortality in hemodialysis patients.
Zhang Y, Thamer M, Stefanik K, Kaufman J, Cotter DJ. Zhang Y, et al. Among authors: kaufman j. Am J Kidney Dis. 2004 Nov;44(5):866-76. Am J Kidney Dis. 2004. PMID: 15492953
Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients.
Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B, Pasticci F, Kaufman JM, Buoncristiani U. Fagugli RM, et al. Among authors: kaufman jm. Am J Kidney Dis. 2001 Aug;38(2):371-6. doi: 10.1053/ajkd.2001.26103. Am J Kidney Dis. 2001. PMID: 11479164 Clinical Trial.
Major declines in epoetin dosing after prospective payment system based on dialysis facility organizational status.
Thamer M, Zhang Y, Kaufman J, Kshirsagar O, Cotter D, Hernán MA. Thamer M, et al. Among authors: kaufman j. Am J Nephrol. 2014;40(6):554-60. doi: 10.1159/000370334. Epub 2015 Jan 10. Am J Nephrol. 2014. PMID: 25592645 Free PMC article.
Comparative effectiveness of two anemia management strategies for complex elderly dialysis patients.
Zhang Y, Thamer M, Kaufman J, Cotter D, Hernán MA. Zhang Y, et al. Among authors: kaufman j. Med Care. 2014 Mar;52 Suppl 3(0 3):S132-9. doi: 10.1097/MLR.0b013e3182a53ca8. Med Care. 2014. PMID: 24561752 Free PMC article. Clinical Trial.
Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the United States.
Zhang Y, Thamer M, Cotter D, Kaufman J, Hernán MA. Zhang Y, et al. Among authors: kaufman j. Clin J Am Soc Nephrol. 2009 Mar;4(3):638-44. doi: 10.2215/CJN.05071008. Epub 2009 Mar 4. Clin J Am Soc Nephrol. 2009. PMID: 19261818 Free PMC article.
Route of epoetin administration influences hemoglobin variability in hemodialysis patients.
Patel T, Hirter A, Kaufman J, Keithi-Reddy SR, Reda D, Singh A. Patel T, et al. Among authors: kaufman j. Am J Nephrol. 2009;29(6):532-7. doi: 10.1159/000187649. Epub 2008 Oct 21. Am J Nephrol. 2009. PMID: 19088467 Free PMC article.
Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis: the authors respond.
Thamer M, Zhang Y, Kaufman J, Cotter D, Hernán MA. Thamer M, et al. Among authors: kaufman j. Am J Kidney Dis. 2007 Oct;50(4):538-41. doi: 10.1053/j.ajkd.2007.08.001. Am J Kidney Dis. 2007. PMID: 17900452 No abstract available.
Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis.
Thamer M, Zhang Y, Kaufman J, Cotter D, Dong F, Hernán MA. Thamer M, et al. Among authors: kaufman j. JAMA. 2007 Apr 18;297(15):1667-74. doi: 10.1001/jama.297.15.1667. JAMA. 2007. PMID: 17440144
Factors influencing route of administration for epoetin treatment among hemodialysis patients in the United States.
Thamer M, Zhang Y, Kaufman J, Stefanik K, Cotter DJ. Thamer M, et al. Among authors: kaufman j. Am J Kidney Dis. 2006 Jul;48(1):77-87. doi: 10.1053/j.ajkd.2006.03.040. Am J Kidney Dis. 2006. PMID: 16797389
Hematocrit was not validated as a surrogate end point for survival among epoetin-treated hemodialysis patients.
Cotter DJ, Stefanik K, Zhang Y, Thamer M, Scharfstein D, Kaufman J. Cotter DJ, et al. Among authors: kaufman j. J Clin Epidemiol. 2004 Oct;57(10):1086-95. doi: 10.1016/j.jclinepi.2004.05.002. J Clin Epidemiol. 2004. PMID: 15528060
3,088 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback